The spectrum of airway dysfunction in asthma: a focus on small airways from the Turkish adult asthma registry

Small airway dysfunction (SAD) increases airway resistance, impacting asthma outcomes and lung function. We aimed to determine the distribution of SAD and to describe its clinical and functional features within the spectrum of airway involvement in adult asthmatics. This cross-sectional study is a subgroup analysis of the multicenter Turkish Adult Asthma Registry (TAAR) between 2018–2022. Patients were classified into three functional groups based on pulmonary function tests: normal lung function (NLF; FEV1≥80%, FEF25–75% ≥65%), SAD (FEV ≥80%, FEF25–75%<65%), and large-small airway dysfunction (LSAD; FEV1<80%, FEF25–75%<65%). Clinical characteristics, asthma phenotypes, and spirometric indices were compared across groups. Among 989 patients, 347(35.1%) were classified as NLF, 232(23.5%) as SAD, and 410(41.5%) as LSAD. Patients with NLF were younger with shorter disease duration, whereas obese asthma, poorer asthma control, higher GINA step, and severe asthma were more frequent in LSAD. Well-controlled asthma was observed in 56.6%, 50.2%, and 34.0% of patients with NLF, SAD, and LSAD, respectively. Median FEV1, FEV1/FVC, and FEF25–75% values showed a graded decline from NLF to SAD and LSAD (all p < 0.001). In allergic and in eosinophilic asthma, FEV1 and FEF25–75% were lower in SAD than in NLF, and LSAD had the lowest values. In this multicenter registry sub-analysis, SAD was present in approximately one quarter of adult asthmatics and showed an intermediate clinical–functional profile between NLF and LSAD, with poorer asthma control and greater treatment intensity than NLF but less impairment than LSAD. These findings position SAD as a distinct intermediate stage of airway dysfunction and suggest that identifying SAD may help quantify disease burden and refine treatment strategies, particularly in type-2 phenotypes.

Authors

Publication Details

Journal
Figshare
Published
2026-11-19
DOI
https://doi.org/10.6084/m9.figshare.35055102
Primary Topic
Asthma and respiratory diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The spectrum of airway dysfunction in asthma: a focus on small airways from the Turkish adult asthma registry

Gülistan Alpagat, Murat Türk, Şadan Soyyiğit, Mehmet Erdem Çakmak et al.
Figshare
Asthma and respiratory diseases
article

The spectrum of airway dysfunction in asthma: a focus on small airways from the Turkish adult asthma registry

Gülistan Alpagat, Murat Türk, Şadan Soyyiğit, Mehmet Erdem Çakmak, Gülden Paşaoğlu Karakış, Sibel Atış Naycı, Ayşe Baççıoğlu, Yavuz Havlucu, Bilun Gemicioğlu, Dane Ediger, Ayşe Bilge Öztürk, Aliye Candan Öğüş, Zeynep Yeğin Katran, İpek Kıvılcım Oğuzülgen, Halil Dönmez, Gülfem Çelík, Fatma Merve Tepetam, Alı Fuat Kalyoncu, Hülya Dirol, Nurgül Bozkurt, Cihan Örçen, Adile Berna Dursun, Selen Karaoğlanoğlu, Eylem Sercan Özgür, Ayse Feyza Aslan, Mehmet Polatlı, Elif Yelda Özgün Niksarlıoğlu, Fatma Esra Günaydın, Ayşe Füsun Kalpaklıoğlu, Elif Yilmazer Ucar, Demet Polat Yuluğ, İlknur Başyiğit, Bilge YILMAZ KARA, Semra Demir, İlkay Koca Kalkan, Tuğçe Yakut, Şeyma Özden, Ahmet Emre Süslü, Serdar Özer, Şule Taş Gülen, Emel Çadallı Tatar, Serap Argun Barış, Münevver Erdinç, Reşat Kendirlinan, Gülseren Pekbak, Leyla Pur Özyiğit, Pamir Çerçi, Yasemin Yavuz, İnsu Yılmaz, Dilşad Mungan, Arzu Yorgancıoğlu, Ömür Aydın, Öznur Abadoğlu, Derya Ünal, Can Sevinç, Deniz Kızılırmak, Murat Kavas, Metin Keren, İrfan Yorulmaz, Enes Furkan Aykaç, Özcan Gül, Reyhan Gümüşburun, Mehmet Atilla Uysal, Sacide Rana Işık, Sinem İnan, Gül Karakaya, Gözde Köycü Buhari, Bulent Akkurt, Şengül Beyaz, Asli Akkor Gelincik, Müge Erbay, Yonca Sekibağ, Oğuz Uzun, Ümmühan Şeker, Füsun Yıldız, Ebru Damadoğlu, Dilek Karadoğan, Zahide Çiler Büyükatalay, Sümeyra Alan Yalım, Engin Dursun, Özlem Göksel, Funda Seher Özalp Ateş, Gülhan Boğatekin, Hatice Serpil Akten, Taşkın Yücel, Saltuk Buğra Kaya, İsmet Bulut, Bahar Aslan, Derya Gokmen, Gökçen Ömeroğlu Şimşek, Seçil Kepil Özdemir, Ferda Oner Erkekol, Gülden Paçacı Çetin, Zeynep Çelebi Sözener, Ali Can, Ali Cengiz, Tuba Erdoğan
article en

Abstract

Small airway dysfunction (SAD) increases airway resistance, impacting asthma outcomes and lung function. We aimed to determine the distribution of SAD and to describe its clinical and functional features within the spectrum of airway involvement in adult asthmatics. This cross-sectional study is a subgroup analysis of the multicenter Turkish Adult Asthma Registry (TAAR) between 2018–2022. Patients were classified into three functional groups based on pulmonary function tests: normal lung function (NLF; FEV1≥80%, FEF25–75% ≥65%), SAD (FEV ≥80%, FEF25–75%<65%), and large-small airway dysfunction (LSAD; FEV1<80%, FEF25–75%<65%). Clinical characteristics, asthma phenotypes, and spirometric indices were compared across groups. Among 989 patients, 347(35.1%) were classified as NLF, 232(23.5%) as SAD, and 410(41.5%) as LSAD. Patients with NLF were younger with shorter disease duration, whereas obese asthma, poorer asthma control, higher GINA step, and severe asthma were more frequent in LSAD. Well-controlled asthma was observed in 56.6%, 50.2%, and 34.0% of patients with NLF, SAD, and LSAD, respectively. Median FEV1, FEV1/FVC, and FEF25–75% values showed a graded decline from NLF to SAD and LSAD (all p < 0.001). In allergic and in eosinophilic asthma, FEV1 and FEF25–75% were lower in SAD than in NLF, and LSAD had the lowest values. In this multicenter registry sub-analysis, SAD was present in approximately one quarter of adult asthmatics and showed an intermediate clinical–functional profile between NLF and LSAD, with poorer asthma control and greater treatment intensity than NLF but less impairment than LSAD. These findings position SAD as a distinct intermediate stage of airway dysfunction and suggest that identifying SAD may help quantify disease burden and refine treatment strategies, particularly in type-2 phenotypes.

Figshare
Asthma and respiratory diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon